Exciting news for patients! Xiidra is covered for approx 90%* of patients across Commercial and Medicare prescription plans!
Your eye doctor may call it "chronic dry eye," or simply "dry eye." No matter what you call it, dry eye is a pretty common eye condition. It can also be pretty annoying, interrupting you while you read, drive, watch TV, or sneak in a little online shopping.
Dry eye is chronic and may be progressive. One of the major possible factors in the cycle of chronic dry eye is inflammation. Read on to learn how Xiidra targets a source of inflammation that can cause chronic dry eye.
*Based on data from February 2024. Up to 71% of Medicare Part D and 94% of commercial patients may be covered.
Medications such as antihistamines
Prolonged screen time
Sex (women may be at higher risk)
Wearing contact lenses
Living in environments with low humidity
Changes in hormones
Aging
This is a simplified depiction of what may occur in dry eye disease.
Over time, dry eye can be more than annoying—symptoms can keep coming back. If your dry eye symptoms are persistent, inflammation in your eye may be to blame. Inflammation may lead to chronic dry eye.
Healthy tears help lubricate and protect the surface of the eye. Various factors such as when you have poor-quality tears or do not produce enough tears, can damage the surface of the eye and contribute to dry eye disease. It is thought that dry eye can be chronic and may be progressive.
For people with dry eye, artificial tears are often the first line of treatment. They typically work to lubricate the eyes and can provide temporary relief. If you're using artificial tears like your eye doctor recommended and your symptoms keep coming back, don't ignore it—ask if you need something that works differently.
†Over-the-counter eye drops=artificial tears.
It targets a source of inflammation that can cause chronic dry eye. It can provide lasting symptom relief in some patients with continued twice-daily use.‡
‡In clinical studies, Xiidra was shown to, on average, reduce symptoms of eye dryness by weeks 6 and 12, provide relief for some patients in as little as 2 weeks (in 2 out of 4 studies), and reduce signs of dry eye (the things your doctor can assess) at week 12 in some patients (in 3 out of 4 studies).
Xiidra (lifitegrast ophthalmic solution) 5% is a prescription eye drop used to treat the signs and symptoms of dry eye disease.
Do not use Xiidra if you are allergic to any of its ingredients. Seek medical care immediately if you get any symptoms of an allergic reaction.
The most common side effects of Xiidra include eye irritation, discomfort or blurred vision when the drops are applied to the eyes, and an unusual taste sensation.
Xiidra (lifitegrast ophthalmic solution) 5% is a prescription eye drop used to treat the signs and symptoms of dry eye disease.
Do not use Xiidra if you are allergic to any of its ingredients. Seek medical care immediately if you get any symptoms of an allergic reaction.
The most common side effects of Xiidra include eye irritation, discomfort or blurred vision when the drops are applied to the eyes, and an unusual taste sensation.
To help avoid eye injury or contamination of the solution, do not touch the container tip to your eye or any surface. If you wear contact lenses, remove them before using Xiidra and wait for at least 15 minutes before placing them back in your eyes.
It is not known if Xiidra is safe and effective in children under 17 years of age.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Xiidra (lifitegrast ophthalmic solution) 5% is a prescription eye drop used to treat the signs and symptoms of dry eye disease.
For additional safety information, click here for Full Prescribing Information and Patient Information and discuss with your doctor.
§Limitations apply. Eligible, commercially insured patients using the Xiidra Savings Card pay $0 for their first prescription of Xiidra for up to 90 days. After the first fill, eligible, commercially insured patients may pay as little as $0 for prescriptions of Xiidra, subject to a maximum monthly savings of $250 for a 30-day prescription and $750 for a 90-day prescription. Offer not valid under Medicare, Medicaid, or any other federal or state program. Bausch + Lomb reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions for details.
*Based on data from February 2024. Up to 71% of Medicare Part D and 94% of commercial patients may be covered.
